Clinical Trials Open To Enrollment

  • An 18-month trial investigating an infusion-based medication (infusions done in clinic) which may target amyloid plaque in the brain. This study is for individuals with mild cognitive impairment. We also have a similar 24-month study for individuals with mild Alzheimer’s disease. For more information, please visit the study website.

  • An 18-month trial investigating an oral medication, which may inhibit a particular enzyme known to be part of the amyloid production process. This study is for individuals with mild Alzheimer’s disease. For more information, please visit the study website.

  • An 8-month trial investigating a coconut oil beverage in individuals with mild to moderate Alzheimer’s disease. For more information, please see study flyer.

  • A 1-year study investigating an oral medication drug that may benefit synaptic communications between brain cells. For more information, please see study flyer. 

  • A 3 ½ - year prevention study in which participants may receive an amyloid-targeting treatment for individuals 65-85 years old who are at risk for Alzheimer’s disease (have a family history, test positive on an amyloid PET scan, etc) but currently have no memory problems. For more information, please view study flyer.

  • A 6-month study investigating an oral medication that may block the signal of a nregative receptor and may increase signaling of neurons in the brain. Subjects must be on 10mg of donepezil and a stable dose of memantine. For more information, please visit the study website. 

We always have new trials just around the corner! Please check back with us for updates! For more information, please contact Jill Smith, MA, CCRC at (813) 974-1294 or jsmith10@health.usf.edu.